Loading insider details...
Beta
Latest Form 4 (Jun 25, 2026): Exercise/Conversion of 9,000 PTGX shares, $148.9K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 25, 2026 | Protagonist Therapeutics, Inc (PTGX) | Exercise/Conversion | 9,000 | $148.9K |
| Jun 15, 2026 | Annexon, Inc. (ANNX) | Grant/Award | 65,000 | n/a |
| Jun 11, 2026 | Protagonist Therapeutics, Inc (PTGX) | Exercise/Conversion | 3,000 | $35.4K |
| Jun 1, 2026 | Protagonist Therapeutics, Inc (PTGX) | Exercise/Conversion | 9,000 | $106.2K |
| Feb 6, 2026 | Protagonist Therapeutics, Inc (PTGX) | Exercise/Conversion | 20,000 | $166.2K |
| Jan 7, 2026 | Protagonist Therapeutics, Inc (PTGX) | Grant/Award | 2,695 | n/a |
| Dec 23, 2025 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Sale | 2,416 | $161.1K |
| Dec 18, 2025 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Grant/Award | 7,819 | n/a |
| Oct 14, 2025 | Protagonist Therapeutics, Inc (PTGX) | Exercise/Conversion | 12,000 | $83.8K |
| Sep 25, 2025 | Protagonist Therapeutics, Inc (PTGX) | Sale | 4,000 | $257.0K |